David J. Heal

7.2k citations

173 papers · 5.8k indexed · 1 hit paper · h-index 41

Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior 95
- Neuroscience and Neuropharmacology Research 46
- Neuropeptides and Animal Physiology 17
Behavioral Neuroscience top 1%
Biological Psychiatry top 2%
Endocrine and Autonomic Systems top 1%
- Regulation of Appetite and Obesity 11
Psychiatry and Mental health top 1%
- Attention Deficit Hyperactivity Disorder 17
Molecular Biology
- Receptor Mechanisms and Signaling 44
Pharmacology
- Pharmacology and Obesity Treatment 18
- Treatment of Major Depression 14

Co-authors: Sharon L. Smith Jane Gosden Sharon C. Cheetham W. R. Buckett David Nutt C.A. Marsden James M. Elliott A. David Smith
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Biological Psychiatry
Partner nations: United Kingdom United States Spain

In The Last Decade

David J. Heal

166 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by David J. Heal

Since Specialization

Citations

This map shows the geographic impact of David J. Heal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Heal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Heal more than expected).

Fields of papers citing papers by David J. Heal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Heal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Heal. The network helps show where David J. Heal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David J. Heal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Heal Line = papers co-authored together David J. Heal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of the Abuse Potential of the Cholesterol-24-Hydroxylase Inhibitor, Soticlestat, in Drug-Discrimination and Self-Administration Tests David J. Heal,Sharon Rowton,Sharon L. Smith,Jane Gosden,Kristin H. Horn,Gvido Cebers,James L. Blank	2025	0
2	Assessment of Withdrawal-Induced Physical Dependence in Rats After Administration of the Potent Cholesterol-24-Hydroxylase Inhibitor, Soticlestat Sharon Rowton,David J. Heal,Sharon L. Smith,Jane Gosden,Kristin H. Horn,Gvido Cebers,James L. Blank	2025	0
3	Psychedelic research – Going global David J. Heal,Sharon L. Smith,Jack E. Henningfield	2025	0
4	Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling Jack E. Henningfield,Marion A. Coe,Roland R. Griffiths,Sean J. Belouin,Ann Berger,Allison R. Coker,Sandra D. Comer,David J. Heal,Peter S. Hendricks,Charles D. Nichols,Frank Sapienza,Frank J. Vocci,Farah Zia	2022	25
5	Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence Richard A. Gray,David J. Heal,David R. Maguire,Lisa R. Gerak,Martin A. Javors,Sarah E. Smith,Charles P. France	2022	8
6	Assessment of ropinirole as a reinforcer in rhesus monkeys Kevin B. Freeman,David J. Heal,Andrew C. McCreary,William L. Woolverton	2012	8
7	The 5-HT6 Receptor as a Target for Developing Novel Antiobesity Drugs David J. Heal,Jane Gosden,Sharon L. Smith	2011	25
8	5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354 Sandrine M. Géranton,David J. Heal,S. Clare Stanford	2004	4
9	Noradrenaline clearance differs in the frontal cortex and hypothalamus: a dual-probe microdialysis study in freely-moving rats Sandrine M. Géranton,David J. Heal,S. Clare Stanford	2003	3
10	Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d‐amphetamine: modulation by α₂‐adrenoceptors Katherine E. Wortley,Zoë A. Hughes,David J. Heal,S. Clare Stanford	1999	24
11	Mediation of mydriasis in conscious rats by central postsynaptic α2-adrenoceptors David J. Heal	1995	15
12	Evidence for altered α2-adrenoceptor function following isolation-rearing in the rat Allison Fulford,Sarah Butler,David J. Heal,David A. Kendall,C.A. Marsden	1994	28
13	Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT_1A receptors Graham P. Luscombe,Keith F. Martin,Lisa J. Hutchins,Jane Gosden,David J. Heal	1993	73
14	[3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments Sharon C. Cheetham,Jean Viggers,Nigel K.H. Slater,David J. Heal,W. R. Buckett	1993	109
15	Central serotonin receptors and psychotropic drugs C.A. Marsden,David J. Heal	1992	48
16	A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride David J. Heal,Michael R. Prow,Jane Gosden,Graham P. Luscombe,W. R. Buckett	1992	11
17	Opposing roles for 5‐HT_1Band 5‐HT₃receptors in the control of 5‐HT release in rat hippocampusin vivo Keith F. Martin,Serina D Hannon,Ian Phillips,David J. Heal	1992	86
18	The Pharmacology of noradrenaline in the central nervous system David J. Heal,C.A. Marsden	1990	125
19	Clonidine produces mydriasis in conscious mice by activating central α2-adrenoceptors David J. Heal,Michael R. Prow,W. R. Buckett	1989	14
20	Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β₁ but Not β₂‐Adrenoceptors in Rat Cortex David J. Heal,Sarah Butler,E. M. Hurst,W. R. Buckett	1989	50

About David J. Heal

David J. Heal is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Toxicology, having authored 173 papers that have together received 5.8k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (95 papers), Neuroscience and Neuropharmacology Research (46 papers), Receptor Mechanisms and Signaling (44 papers), Pharmacology and Obesity Treatment (18 papers), Neuropeptides and Animal Physiology (17 papers), Attention Deficit Hyperactivity Disorder (17 papers), Treatment of Major Depression (14 papers) and Regulation of Appetite and Obesity (11 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.2k citations), Behavioral Neuroscience (492 citations) and Biological Psychiatry (215 citations). David J. Heal has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Sharon L. Smith, Jane Gosden, Sharon C. Cheetham, W. R. Buckett, David Nutt, C.A. Marsden, James M. Elliott, A. David Smith, Guy M. Goodwin and Keith F. Martin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact